HEADER DE NOVO PROTEIN 11-SEP-24 9GRK TITLE CDC42 BINDING PEPTIDE (W14A) COMPND MOL_ID: 1; COMPND 2 MOLECULE: PRO-SER-ILE-CYS-HIS-VAL-HIS-ARG-PRO-ASP-TRP-PRO-CYS-ALA- COMPND 3 TYR-ARG; COMPND 4 CHAIN: A; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 4 ORGANISM_TAXID: 32630 KEYWDS PEPTIDE; CDC42 BINDING., DE NOVO PROTEIN EXPDTA SOLUTION NMR NUMMDL 35 AUTHOR H.R.MOTT,N.P.MURPHY,D.OWEN REVDAT 1 11-FEB-26 9GRK 0 JRNL AUTH N.P.MURPHY,G.J.N.TETLEY,J.REVELL,H.R.MOTT,D.OWEN JRNL TITL CYCLIZED PEPTIDE INHIBITORS OF THE SMALL G PROTEIN CDC42 JRNL TITL 2 MIMIC BINDING OF EFFECTOR PROTEINS. JRNL REF BIOCHEMISTRY 2026 JRNL REFN ISSN 0006-2960 JRNL PMID 41566164 JRNL DOI 10.1021/ACS.BIOCHEM.5C00616 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER, ADAMS, CLORE, GROS, NILGES AND READ REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 9GRK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 11-SEP-24. REMARK 100 THE DEPOSITION ID IS D_1292141654. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 7.0 REMARK 210 IONIC STRENGTH : 50 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 0.7 MM PEPTIDE, 50 MM SODIUM REMARK 210 PHOSPHATE, 90% H2O/10% D2O; 0.8 REMARK 210 MM [U-100% 15N] PEPTIDE, 50 MM REMARK 210 SODIUM PHOSPHATE, 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 3D 1H-15N NOESY; REMARK 210 3D 1H-15N TOCSY; 2D 1H-1H NOESY; REMARK 210 2D 1H-1H TOCSY REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ; 800 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CCPNMR ANALYSIS 2.4, ARIA REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 35 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 SER A 2 -64.00 -129.82 REMARK 500 1 ILE A 3 -41.89 -172.31 REMARK 500 1 VAL A 6 160.19 178.08 REMARK 500 1 HIS A 7 -57.47 -151.81 REMARK 500 1 CYS A 13 -52.05 -161.00 REMARK 500 1 ALA A 14 4.11 -177.90 REMARK 500 2 VAL A 6 147.11 77.34 REMARK 500 2 HIS A 7 -49.35 -152.12 REMARK 500 2 PRO A 12 -94.70 -73.17 REMARK 500 2 CYS A 13 70.20 -161.63 REMARK 500 3 ILE A 3 -42.23 -165.84 REMARK 500 3 HIS A 7 -41.76 -163.36 REMARK 500 3 CYS A 13 -48.94 -163.49 REMARK 500 3 ALA A 14 19.04 179.58 REMARK 500 4 ILE A 3 -32.90 -169.92 REMARK 500 4 HIS A 7 -26.30 -158.00 REMARK 500 4 CYS A 13 -52.43 -161.10 REMARK 500 4 ALA A 14 22.17 179.62 REMARK 500 5 CYS A 4 -165.80 -171.93 REMARK 500 5 HIS A 5 -168.77 -117.72 REMARK 500 5 HIS A 7 -53.76 -135.76 REMARK 500 5 PRO A 12 -113.58 -75.34 REMARK 500 5 ALA A 14 54.33 -178.92 REMARK 500 6 ILE A 3 -48.20 -159.83 REMARK 500 6 HIS A 5 -64.55 -90.83 REMARK 500 6 VAL A 6 -38.92 -177.29 REMARK 500 6 HIS A 7 -81.34 41.37 REMARK 500 6 CYS A 13 -52.50 177.84 REMARK 500 6 ALA A 14 13.64 176.98 REMARK 500 7 ILE A 3 -37.21 -151.80 REMARK 500 7 CYS A 4 -156.93 -163.73 REMARK 500 7 HIS A 7 -41.93 -141.91 REMARK 500 7 PRO A 12 -100.84 -72.26 REMARK 500 7 CYS A 13 -55.55 -122.85 REMARK 500 7 ALA A 14 73.86 175.33 REMARK 500 7 TYR A 15 -55.99 -136.70 REMARK 500 8 ILE A 3 -35.82 -168.87 REMARK 500 8 HIS A 5 -65.07 -98.86 REMARK 500 8 HIS A 7 -56.36 -155.19 REMARK 500 8 PRO A 12 -71.62 -76.58 REMARK 500 8 CYS A 13 -54.82 -149.51 REMARK 500 8 ALA A 14 17.68 -178.14 REMARK 500 9 HIS A 5 -86.55 -102.30 REMARK 500 9 HIS A 7 -6.31 -145.25 REMARK 500 9 PRO A 12 -81.00 -69.03 REMARK 500 9 CYS A 13 -55.50 -141.77 REMARK 500 9 ALA A 14 21.48 177.89 REMARK 500 10 HIS A 7 -55.02 -158.31 REMARK 500 10 CYS A 13 -52.61 -166.11 REMARK 500 10 ALA A 14 18.42 176.78 REMARK 500 REMARK 500 THIS ENTRY HAS 187 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 34956 RELATED DB: BMRB REMARK 900 CDC42 BINDING PEPTIDE (W14A) DBREF 9GRK A 1 16 PDB 9GRK 9GRK 1 16 SEQRES 1 A 16 PRO SER ILE CYS HIS VAL HIS ARG PRO ASP TRP PRO CYS SEQRES 2 A 16 ALA TYR ARG SSBOND 1 CYS A 4 CYS A 13 1555 1555 2.03 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1 ENDMDL MODEL 2 ENDMDL MODEL 3 ENDMDL MODEL 4 ENDMDL MODEL 5 ENDMDL MODEL 6 ENDMDL MODEL 7 ENDMDL MODEL 8 ENDMDL MODEL 9 ENDMDL MODEL 10 ENDMDL MODEL 11 ENDMDL MODEL 12 ENDMDL MODEL 13 ENDMDL MODEL 14 ENDMDL MODEL 15 ENDMDL MODEL 16 ENDMDL MODEL 17 ENDMDL MODEL 18 ENDMDL MODEL 19 ENDMDL MODEL 20 ENDMDL MODEL 21 ENDMDL MODEL 22 ENDMDL MODEL 23 ENDMDL MODEL 24 ENDMDL MODEL 25 ENDMDL MODEL 26 ENDMDL MODEL 27 ENDMDL MODEL 28 ENDMDL MODEL 29 ENDMDL MODEL 30 ENDMDL MODEL 31 ENDMDL MODEL 32 ENDMDL MODEL 33 ENDMDL MODEL 34 ENDMDL MODEL 35 ENDMDL CONECT 52 202 CONECT 202 52 MASTER 144 0 0 0 0 0 0 6 136 1 2 2 END